COVID-19 Impact on Global General Anxiety Disorder Therapeutics Market Size, Status and Forecast 2020-2026

September 2020 | 90 pages | ID: CDE9F0F40B63EN
QYResearch

Abstracts

This report focuses on the global General Anxiety Disorder Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the General Anxiety Disorder Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Bionomics Limited
• Edgemont Pharmaceuticals, LLC
• H. Lundbeck A/S

Market segment by Type, the product can be split into

• Itriglumide
• Tedatioxetine
• EDG-004
• Others

Market segment by Application, split into

• Clinic
• Hospital
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global General Anxiety Disorder Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the General Anxiety Disorder Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of General Anxiety Disorder Therapeutics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by General Anxiety Disorder Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global General Anxiety Disorder Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Itriglumide
  1.4.3 Tedatioxetine
  1.4.4 EDG-004
  1.4.5 Others
1.5 Market by Application
  1.5.1 Global General Anxiety Disorder Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Clinic
  1.5.3 Hospital
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): General Anxiety Disorder Therapeutics Industry Impact
  1.6.1 How the Covid-19 is Affecting the General Anxiety Disorder Therapeutics Industry
    1.6.1.1 General Anxiety Disorder Therapeutics Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and General Anxiety Disorder Therapeutics Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for General Anxiety Disorder Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 General Anxiety Disorder Therapeutics Market Perspective (2015-2026)
2.2 General Anxiety Disorder Therapeutics Growth Trends by Regions
  2.2.1 General Anxiety Disorder Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 General Anxiety Disorder Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 General Anxiety Disorder Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 General Anxiety Disorder Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key General Anxiety Disorder Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top General Anxiety Disorder Therapeutics Players by Market Size
  3.1.1 Global Top General Anxiety Disorder Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global General Anxiety Disorder Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global General Anxiety Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global General Anxiety Disorder Therapeutics Market Concentration Ratio
  3.2.1 Global General Anxiety Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by General Anxiety Disorder Therapeutics Revenue in 2019
3.3 General Anxiety Disorder Therapeutics Key Players Head office and Area Served
3.4 Key Players General Anxiety Disorder Therapeutics Product Solution and Service
3.5 Date of Enter into General Anxiety Disorder Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global General Anxiety Disorder Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global General Anxiety Disorder Therapeutics Forecasted Market Size by Type (2021-2026)

5 GENERAL ANXIETY DISORDER THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global General Anxiety Disorder Therapeutics Market Size by Application (2015-2020)
5.2 Global General Anxiety Disorder Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America General Anxiety Disorder Therapeutics Market Size (2015-2020)
6.2 General Anxiety Disorder Therapeutics Key Players in North America (2019-2020)
6.3 North America General Anxiety Disorder Therapeutics Market Size by Type (2015-2020)
6.4 North America General Anxiety Disorder Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe General Anxiety Disorder Therapeutics Market Size (2015-2020)
7.2 General Anxiety Disorder Therapeutics Key Players in Europe (2019-2020)
7.3 Europe General Anxiety Disorder Therapeutics Market Size by Type (2015-2020)
7.4 Europe General Anxiety Disorder Therapeutics Market Size by Application (2015-2020)

8 CHINA

8.1 China General Anxiety Disorder Therapeutics Market Size (2015-2020)
8.2 General Anxiety Disorder Therapeutics Key Players in China (2019-2020)
8.3 China General Anxiety Disorder Therapeutics Market Size by Type (2015-2020)
8.4 China General Anxiety Disorder Therapeutics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan General Anxiety Disorder Therapeutics Market Size (2015-2020)
9.2 General Anxiety Disorder Therapeutics Key Players in Japan (2019-2020)
9.3 Japan General Anxiety Disorder Therapeutics Market Size by Type (2015-2020)
9.4 Japan General Anxiety Disorder Therapeutics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia General Anxiety Disorder Therapeutics Market Size (2015-2020)
10.2 General Anxiety Disorder Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia General Anxiety Disorder Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia General Anxiety Disorder Therapeutics Market Size by Application (2015-2020)

11 INDIA

11.1 India General Anxiety Disorder Therapeutics Market Size (2015-2020)
11.2 General Anxiety Disorder Therapeutics Key Players in India (2019-2020)
11.3 India General Anxiety Disorder Therapeutics Market Size by Type (2015-2020)
11.4 India General Anxiety Disorder Therapeutics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America General Anxiety Disorder Therapeutics Market Size (2015-2020)
12.2 General Anxiety Disorder Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America General Anxiety Disorder Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America General Anxiety Disorder Therapeutics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Bionomics Limited
  13.1.1 Bionomics Limited Company Details
  13.1.2 Bionomics Limited Business Overview and Its Total Revenue
  13.1.3 Bionomics Limited General Anxiety Disorder Therapeutics Introduction
  13.1.4 Bionomics Limited Revenue in General Anxiety Disorder Therapeutics Business (2015-2020))
  13.1.5 Bionomics Limited Recent Development
13.2 Edgemont Pharmaceuticals, LLC
  13.2.1 Edgemont Pharmaceuticals, LLC Company Details
  13.2.2 Edgemont Pharmaceuticals, LLC Business Overview and Its Total Revenue
  13.2.3 Edgemont Pharmaceuticals, LLC General Anxiety Disorder Therapeutics Introduction
  13.2.4 Edgemont Pharmaceuticals, LLC Revenue in General Anxiety Disorder Therapeutics Business (2015-2020)
  13.2.5 Edgemont Pharmaceuticals, LLC Recent Development
13.3 H. Lundbeck A/S
  13.3.1 H. Lundbeck A/S Company Details
  13.3.2 H. Lundbeck A/S Business Overview and Its Total Revenue
  13.3.3 H. Lundbeck A/S General Anxiety Disorder Therapeutics Introduction
  13.3.4 H. Lundbeck A/S Revenue in General Anxiety Disorder Therapeutics Business (2015-2020)
  13.3.5 H. Lundbeck A/S Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. General Anxiety Disorder Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by General Anxiety Disorder Therapeutics Revenue
Table 3. Ranking of Global Top General Anxiety Disorder Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global General Anxiety Disorder Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Itriglumide
Table 6. Key Players of Tedatioxetine
Table 7. Key Players of EDG-004
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four General Anxiety Disorder Therapeutics Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for General Anxiety Disorder Therapeutics Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for General Anxiety Disorder Therapeutics Players to Combat Covid-19 Impact
Table 14. Global General Anxiety Disorder Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global General Anxiety Disorder Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global General Anxiety Disorder Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global General Anxiety Disorder Therapeutics Market Share by Regions (2015-2020)
Table 18. Global General Anxiety Disorder Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global General Anxiety Disorder Therapeutics Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. General Anxiety Disorder Therapeutics Market Growth Strategy
Table 24. Main Points Interviewed from Key General Anxiety Disorder Therapeutics Players
Table 25. Global General Anxiety Disorder Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 26. Global General Anxiety Disorder Therapeutics Market Share by Players (2015-2020)
Table 27. Global Top General Anxiety Disorder Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in General Anxiety Disorder Therapeutics as of 2019)
Table 28. Global General Anxiety Disorder Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players General Anxiety Disorder Therapeutics Product Solution and Service
Table 31. Date of Enter into General Anxiety Disorder Therapeutics Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global General Anxiety Disorder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 34. Global General Anxiety Disorder Therapeutics Market Size Share by Type (2015-2020)
Table 35. Global General Anxiety Disorder Therapeutics Revenue Market Share by Type (2021-2026)
Table 36. Global General Anxiety Disorder Therapeutics Market Size Share by Application (2015-2020)
Table 37. Global General Anxiety Disorder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 38. Global General Anxiety Disorder Therapeutics Market Size Share by Application (2021-2026)
Table 39. North America Key Players General Anxiety Disorder Therapeutics Revenue (2019-2020) (Million US$)
Table 40. North America Key Players General Anxiety Disorder Therapeutics Market Share (2019-2020)
Table 41. North America General Anxiety Disorder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 42. North America General Anxiety Disorder Therapeutics Market Share by Type (2015-2020)
Table 43. North America General Anxiety Disorder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 44. North America General Anxiety Disorder Therapeutics Market Share by Application (2015-2020)
Table 45. Europe Key Players General Anxiety Disorder Therapeutics Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players General Anxiety Disorder Therapeutics Market Share (2019-2020)
Table 47. Europe General Anxiety Disorder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 48. Europe General Anxiety Disorder Therapeutics Market Share by Type (2015-2020)
Table 49. Europe General Anxiety Disorder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 50. Europe General Anxiety Disorder Therapeutics Market Share by Application (2015-2020)
Table 51. China Key Players General Anxiety Disorder Therapeutics Revenue (2019-2020) (Million US$)
Table 52. China Key Players General Anxiety Disorder Therapeutics Market Share (2019-2020)
Table 53. China General Anxiety Disorder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 54. China General Anxiety Disorder Therapeutics Market Share by Type (2015-2020)
Table 55. China General Anxiety Disorder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 56. China General Anxiety Disorder Therapeutics Market Share by Application (2015-2020)
Table 57. Japan Key Players General Anxiety Disorder Therapeutics Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players General Anxiety Disorder Therapeutics Market Share (2019-2020)
Table 59. Japan General Anxiety Disorder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 60. Japan General Anxiety Disorder Therapeutics Market Share by Type (2015-2020)
Table 61. Japan General Anxiety Disorder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 62. Japan General Anxiety Disorder Therapeutics Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players General Anxiety Disorder Therapeutics Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players General Anxiety Disorder Therapeutics Market Share (2019-2020)
Table 65. Southeast Asia General Anxiety Disorder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia General Anxiety Disorder Therapeutics Market Share by Type (2015-2020)
Table 67. Southeast Asia General Anxiety Disorder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia General Anxiety Disorder Therapeutics Market Share by Application (2015-2020)
Table 69. India Key Players General Anxiety Disorder Therapeutics Revenue (2019-2020) (Million US$)
Table 70. India Key Players General Anxiety Disorder Therapeutics Market Share (2019-2020)
Table 71. India General Anxiety Disorder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 72. India General Anxiety Disorder Therapeutics Market Share by Type (2015-2020)
Table 73. India General Anxiety Disorder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 74. India General Anxiety Disorder Therapeutics Market Share by Application (2015-2020)
Table 75. Central & South America Key Players General Anxiety Disorder Therapeutics Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players General Anxiety Disorder Therapeutics Market Share (2019-2020)
Table 77. Central & South America General Anxiety Disorder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America General Anxiety Disorder Therapeutics Market Share by Type (2015-2020)
Table 79. Central & South America General Anxiety Disorder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America General Anxiety Disorder Therapeutics Market Share by Application (2015-2020)
Table 81. Bionomics Limited Company Details
Table 82. Bionomics Limited Business Overview
Table 83. Bionomics Limited Product
Table 84. Bionomics Limited Revenue in General Anxiety Disorder Therapeutics Business (2015-2020) (Million US$)
Table 85. Bionomics Limited Recent Development
Table 86. Edgemont Pharmaceuticals, LLC Company Details
Table 87. Edgemont Pharmaceuticals, LLC Business Overview
Table 88. Edgemont Pharmaceuticals, LLC Product
Table 89. Edgemont Pharmaceuticals, LLC Revenue in General Anxiety Disorder Therapeutics Business (2015-2020) (Million US$)
Table 90. Edgemont Pharmaceuticals, LLC Recent Development
Table 91. H. Lundbeck A/S Company Details
Table 92. H. Lundbeck A/S Business Overview
Table 93. H. Lundbeck A/S Product
Table 94. H. Lundbeck A/S Revenue in General Anxiety Disorder Therapeutics Business (2015-2020) (Million US$)
Table 95. H. Lundbeck A/S Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global General Anxiety Disorder Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Itriglumide Features
Figure 3. Tedatioxetine Features
Figure 4. EDG-004 Features
Figure 5. Others Features
Figure 6. Global General Anxiety Disorder Therapeutics Market Share by Application: 2020 VS 2026
Figure 7. Clinic Case Studies
Figure 8. Hospital Case Studies
Figure 9. Others Case Studies
Figure 10. General Anxiety Disorder Therapeutics Report Years Considered
Figure 11. Global General Anxiety Disorder Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global General Anxiety Disorder Therapeutics Market Share by Regions: 2020 VS 2026
Figure 13. Global General Anxiety Disorder Therapeutics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global General Anxiety Disorder Therapeutics Market Share by Players in 2019
Figure 16. Global Top General Anxiety Disorder Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in General Anxiety Disorder Therapeutics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by General Anxiety Disorder Therapeutics Revenue in 2019
Figure 18. North America General Anxiety Disorder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe General Anxiety Disorder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China General Anxiety Disorder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan General Anxiety Disorder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia General Anxiety Disorder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India General Anxiety Disorder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America General Anxiety Disorder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bionomics Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Bionomics Limited Revenue Growth Rate in General Anxiety Disorder Therapeutics Business (2015-2020)
Figure 27. Edgemont Pharmaceuticals, LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Edgemont Pharmaceuticals, LLC Revenue Growth Rate in General Anxiety Disorder Therapeutics Business (2015-2020)
Figure 29. H. Lundbeck A/S Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. H. Lundbeck A/S Revenue Growth Rate in General Anxiety Disorder Therapeutics Business (2015-2020)
Figure 31. Bottom-up and Top-down Approaches for This Report
Figure 32. Data Triangulation
Figure 33. Key Executives Interviewed